Women's History Month is a time to honor and celebrate the incredible contributions of women throughout history and in our own community. We are proud to recognize the achievements and impact of the women who drive innovation and excellence in our field every day. ? We asked several of the remarkable women leaders here at Altos Labs about how they innovated and grew in their careers – and how we can all support each other in doing the same.? ? Here's what they shared:
Altos Labs
生物技术研究
Altos Labs is a biotechnology company dedicated to unraveling the deep biology of cell rejuvenation to reverse disease.
关于我们
Altos Labs is a biotechnology company focused on restoring cell health and resilience through cell rejuvenation to reverse disease, injury, and the disabilities that can occur throughout life. The company comprises a community of leading scientists, clinicians, and leaders from academia and industry working together towards this common mission. Altos operates in the San Francisco Bay Area, San Diego and Cambridge, UK. Note: Altos Labs will not ask you to download a messaging app for an interview or spend your own money to get started as an employee. If this sounds like your interaction with people claiming to be with Altos, it is not legitimate or a practice within our organization.
- 网站
-
https://www.altoslabs.com
Altos Labs的外部链接
- 所属行业
- 生物技术研究
- 规模
- 201-500 人
- 类型
- 私人持股
- 领域
- biotechnology
Altos Labs员工
动态
-
We are thrilled to share that Principal Investigator Giovanna Mallucci, at our Cambridge Institute of Science, was awarded an honorary doctorate (Doctor Honoris Causa) by Sorbonne Université. This prestigious honor recognizes her outstanding contributions to the field of neuroscience and her dedication to advancing scientific discovery. Congratulations, Giovanna, on this well-deserved recognition!
-
-
Director of the Cambridge Institute of Science Wolf Reik will speak Thursday at the Wellcome Connecting Science Learning and Training Conference on how cutting-edge multi-omics techniques are transforming our understanding of cellular development and aging. Learn more about the event here:?https://lnkd.in/eg98r9bR
-
-
Distinguished Fellow in?AI and ML?Thore Graepel will participate on a panel with Michael Nally and DIMITRIOS ILIOPOULOS tomorrow at The Montgomery Summit on real-world examples of AI-driven breakthroughs in drug discovery. Learn more about the event here: https://lnkd.in/dRk9swgi
-
-
Altos Senior Vice President and Head of Discovery and Development Sciences Dolo Diaz recently spoke with La Nueva Espa?a's Marcos Palicio on finding ways of translating research “into medicines that can reach clinical trials, have the potential to be approved and reach the patients who need them.” Read the full article here:?https://lnkd.in/e9st6iqX
-
This week Altos Labs celebrates 3 years since launch! To mark this occasion we hosted Altos Day events at our three sites to recognize our diverse and exceptional team that makes everything possible. As we look to the future, we are excited about the impact we will make and the opportunities ahead.?
-
-
Congratulations to Altos Labs Principal Investigator Pura Mu?oz-Cánoves for being inducted into The Royal Spanish Academy of Sciences. Watch her talk delivered at the Academy's conference reception on muscle tissue aging here:? https://lnkd.in/eJX46HBc
-
-
At #JPM2025, Altos CEO Hal Barron spoke with Endpoints senior biopharma correspondent Andrew Dunn about the potential of cellular rejuvenation and highlighted Altos Labs' work to pioneer innovations addressing age-related diseases. Register to watch the recording here:?https://lnkd.in/d6jfG2Ff
There was truly no better way to kick off 2025 in the biotech world. Thank you to all who made our Endpoints News @ #JPM25 event a lively, news-packed affair, full of many of the industry's biggest names. A few action ?? shots from these last two days from my conversations with Xaira Therapeutics CEO Marc Tessier-Lavigne, Centerview Partners's E. Eric Tokat, ARCH Venture Partners cofounder Bob Nelsen, Altos Labs CEO Hal Barron, Biogen's Priya Singhal, and Parabilis Medicines CEO Mathai Mammen, M.D., Ph.D. Until JPM26!
-
-
Principal Investigator Jodi Nunnari will present tomorrow at Keystone Symposia on Molecular & Cellular Biology. Her talk will explore mitochondria and interorganellar communication as part of the session on "mitochondrial signaling at different scales." Learn more here:?https://lnkd.in/ekgVm8dx
-
-
Altos CEO Hal Barron will participate in a fireside chat tomorrow with Endpoints senior biopharma correspondent Andrew Dunn followed by a panel discussion on the future of research and development with Mathai Mammen, M.D., Ph.D. and Priya Singhal. Be sure to come by if you're in town for the event and learn more about Endpoints News at #JPM2025 here: https://lnkd.in/eYyFKKbD
-